COEP - Coeptis Therapeutics Holdings, Inc.
13.19
0.730 5.534%
Share volume: 73,589
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.17%
PREVIOUS CLOSE
CHG
CHG%
$12.46
0.73
0.06%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 08-16-2024 | 08-16-2024 | 11-13-2024 | 03-27-2025 | 05-14-2025 | 11-13-2025 | |
| Assets | |||||||
| Total Assets | 3.894 M | 4.198 M | 8.956 M | 8.909 M | 13.453 M | 14.182 M | |
| Current Assets | 1.380 M | 1.991 M | 1.365 M | 1.051 M | 4.651 M | 5.991 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 421.698 K | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 86.041 K | |
| Current Cash | 1.029 M | 1.555 M | 1.137 M | 532.885 K | 4.268 M | 4.908 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 11.095 K | 10.883 K | 10.672 K | 10.460 K | 10.313 K | 10.020 K | |
| Other Assets | 2.503 M | 2.197 M | 7.581 M | 7.847 M | 8.792 M | 8.181 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 3.894 M | 4.198 M | 8.956 M | 8.909 M | 13.453 M | 14.182 M | |
| Total liabilities | 5.035 M | 4.508 M | 3.974 M | 5.041 M | 5.990 M | 3.265 M | |
| Total current liabilities | 4.301 M | 3.626 M | 3.440 M | 4.513 M | 5.652 M | 2.705 M | |
| Accounts Payable | 1.366 M | 1.281 M | 1.134 M | 1.270 M | 1.121 M | 783.103 K | |
| Other liabilities | 583.554 K | 732.804 K | 383.304 K | 378.125 K | 187.999 K | 409.500 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 150.000 K | 150.000 K | 150.000 K | 150.000 K | 150.000 K | 150.000 K | |
| Other liabilities | 583.554 K | 732.804 K | 383.304 K | 378.125 K | 187.999 K | 409.500 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -1.141 M | -442.556 K | 4.825 M | 3.185 M | 6.479 M | 10.366 M | |
| Common stock | 94.717 M | 100.500 M | 102.147 M | 102.977 M | 108.383 M | 120.842 M | |
| Retained earnings | -90.358 M | -93.393 M | -95.222 M | -98.234 M | -101.655 M | -108.376 M |